
Nobipharm sp. z o.o.
Other professional, scientific and technical activities not elsewhere classified
Overview
Nobipharm is a pharmaceutical wholesaler that offers medicinal products in therapeutic areas such as immunoglobulins, albumins, intensive therapy, and hemophilia. The company also provides medical devices and diagnostic equipment.
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 4 of 6 audited by a statutory auditor.
- 2025not filed
- 202426/06/2025
- 202326/06/2024
- 202228/06/2023
- 202122/04/2022
- 202017/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Results vs industry
Industry
Offer
- Medicinal products
- Immunoglobulins
- Albumins
- Medical devices
- Laboratory reagents
Websites
The site is available in: Polish and English.
- nobipharm.plStrona główna – NobipharmWordPress 6.9ElementorPPolylangNginx
Public procurement
378 tenders recorded as contractor: 86 national ($2,696,347) and 292 EU ($27,904,539).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Nov 16, 2026 | Supply of medicines, lots 1–41 | –– | Górnośląskie Centrum Medyczne Im. Prof. Leszka Gieca Śląskiego Uniwersytetu Medycznego w Katowicach | |
| Nov 16, 2026 | Supply of medicines and compounding accessories | $12,858$12,858 | Samodzielny Publiczny Zakład Opieki Zdrowotnej Wojewódzki Szpital Zespolony Im. Jędrzeja Śniadeckiego w Białymstoku | |
| Nov 13, 2026 | Successive supply of medicines to the hospital pharmacy | $35,927$35,927 | Szpital w Ostródzie sp. z o.o. |
The company is the contractor in 95 public sector contracts, worth USD 2.16m in total. They were signed with 54 public buyers.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Nov 16, 2026 | Successive supply of medicinal products | $27,996 | Szpital Im. Św. Jadwigi Śląskiej w Trzebnicy | |
| Nov 10, 2026 | Successive supply of medicinal products | $882.50 | Szpital Im. Św. Jadwigi Śląskiej w Trzebnicy | |
| Nov 10, 2026 | Successive supplies of medicinal products intended for ongoing hospital pharmacotherapy, medical devices and foods for special medical purposes – Lot 50 | $3,350 | Wojewódzki Szpital Wielospecjalistyczny Im. Dr. Jana Jonstona w Lesznie |
Trademarks
The company holds 1 active trademark registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2000.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| NOBIPHARM (word) | Z.393435 | 1, 3, 5, 10, 35, 39, 44 | Protected | Nov 29, 2031 | |
| NOBIPHARM | Z.223066 | 5, 10 | Expired | – |
| Mark | Protected until | |
|---|---|---|
| NOBIPHARM (word) | Nov 29, 2031 | |
| NOBIPHARM | – |
Authorized Representatives
Manner of representation
The President of the Management Board – General Director – independently; in the event of the appointment of a multi-member management board, the President of the Management Board – General Director – independently, two members of the management board jointly, a member of the management board jointly with a commercial proxy, or two commercial proxies jointly.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Krzysztof Nowak age 42 | 330 | $4,457.05 | 33% |
Tomasz Jerzy Nowak age 76 | 670 | $9,049.16 | 67% |
Tomasz Jerzy Nowak and Krzysztof Nowak hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1996-01-01.
49 1750 0009 0000 0000 0094 4769
81 1240 1082 1111 0000 0381 9399
Debt
No entries in the National Debtors Register (KRZ).
Public aid
10 public aid cases recorded, with a total value of $400,785.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 7, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $17,288$17,288 | Prezes Banku Gospodarstwa Krajowego | |
| Mar 11, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $32,145$32,145 | Prezes Banku Gospodarstwa Krajowego | |
| Mar 20, 2024 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $12,027$12,027 | Prezes Banku Gospodarstwa Krajowego |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Medyk-Lek Panek sp. z o.o. sp. k. | $20,167,374.20 | medyklek.pl | ||
| Qpharma sp. z o.o. | $16,010,159.04 | qpharma.pl | ||
| Biomedica Poland sp. z o.o. | $14,278,742.82 | bmgrp.eu | ||
| Allpharm sp. z o.o. sp. k. | $13,461,628.01 | allpharm.pl | ||
| Orion Pharma Poland sp. z o.o. | $13,123,658.19 | orionpharma.pl | ||
| Interpharma sp. z o.o. | $12,321,125.25 | interpharma.com.pl | ||
| Medinn sp. z o.o. | $11,689,415.29 | med-inn.pl | ||
| Trumedico Pl sp. z o.o. + limited partnership | $11,405,243.37 | trumedico.pl | ||
| Bialmed Logistyka sp. z o.o. + limited partnership | $8,349,517.58 | bialmed.com | ||
| Bionesis sp. z o.o. | $7,788,948.87 | bionesis.pl |
Change history
| Date | Event | |
|---|---|---|
| 2006-01-19 | Share capital increase (25,000.00 PLN → 50,000.00 PLN) | |
| 2003-03-03 | Share capital increase (4,000.00 PLN → 25,000.00 PLN) | |
| 2002-04-23 | Entered in the register |
FAQ
Last updated: 2026-04-04